ERGOLEX 0.5 MG 2 TAB
CABERGOLINE
INDICATION FOR THE TREATMENT OF HYPERPROLACTINEMIC DISORDERS EITHER IDIOPATHIC OR DUE TO PROLACTINOMA (PROLACTIN-SECRETING ADENOMAS). MAY ALSO BE USED TO MANAGE SYMPTOMS OF PARKINSONIAN SYNDROME AS MONOTHERAPY DURING INITIAL SYMPTOMATIC MANAGEMENT OR. AS